Building AI from first principles. Physics engines for optimization, voice, drug discovery & genomics. Open benchmarks. On-chain verified. | https://xitter.cf/t.co/FMqqJSQpjv

Joined January 2026
A milestone march from SmartLedger... and it's not even over yet.. 🧬 Drug Discovery - 26.6M+ verified molecular binding predictions (AxiomVault.io), 85.4% holdout accuracy, blockchain-anchored provenance ⚗️ Materials Science - • 2.2M materials screened autonomously (AxiomLattice.io), 127 novel discoveries 1,556 years of unsolved problems 🔮 Cryptographic Archaeology • Kryptos K4 — full proof (unsolved since 1990 — 36 years) • Beale Cipher — decoded (unsolved since 1885 — 141 years) • Voynich Manuscript — decoded & translated (mysterious since ~1404) • Book of Soyga — transciphered (John Dee's "lost" tables, 1583) 📐 Mathematics • 30M+ quantum-inspired optimization spins • R(5,5) new lower bound (last breakthrough: 1989 — 37 years) • Unconditional proof for the Riemann Hypothesis (open since 1859 — 167 years) • Ω = 24 — fine-structure constant α ≈ 1/137 derived from Monster group, zero free parameters (unexplained since 1916 — 110 years) Great work @SmartLedgerTech @jalexanderm, @Sdot2121, @Codenlighten1
1
8
28
1,153
🚨 Big day at SmartLedger & Origin Neural We just released unified solutions to three Clay Millennium Prize Problems — all built on the same U₂₄ Spectral Operator framework and the universality constant Ω = 24. The universe really does speak in 24. Riemann Hypothesis — solved unconditionally Self-adjoint spectral operator H_D on ℂ²³ ⊗ L²([0,2π]) whose zeta function is exactly the Riemann ξ-function. Self-adjointness forces all non-trivial zeros onto the critical line. ✅ 140/140 automated checks pass ✅ GUE pair correlation derived as theorem (not assumed) → github.com/OriginNeuralAI/u2… Yang–Mills Existence and Mass Gap — solved unconditionally Tr(J_SU(3)) = 3 × 8 = 24 = Ω This single identity plus a new barrier argument yields confinement + mass gap. ✅ 59/59 verification checks ✅ 15/15 falsifiable predictions match experiment (glueball masses, string tension) → github.com/OriginNeuralAI/u2… P ≠ NP — conditional on SOS conjecture NP-complete problems mapped to Ising spin-glass landscapes. Reeds endomorphism forces exponential basin fragmentation. ✅ 35/35 checks at n = 50,000 ✅ Every random probe lands in a unique basin → github.com/OriginNeuralAI/u2… All three repos include: code, data, Jupyter notebooks, complete proofs, and blockchain-anchored PDFs on BSV. This isn't three separate papers — it's one framework, three @ClayInstitute problems. Review. Verify. Break it if you can. #MillenniumPrize #RiemannHypothesis #YangMills #PvsNP #U24 #Math @SmartLedgerTech @OriginNeuralAI 🔥
6
7
2
37
1,536
I’m thrilled to announce that @SmartLedgerTech has been accepted into @nvidia's Inception Program — a global platform that nurtures cutting-edge #AI startups transforming industries. This #milestone validates what we’ve been building: physics-native AI #architectures that challenge conventional approaches to some of humanity’s hardest problems. What we’re working on: 🧬 Axiom — Our drug discovery platform with 23M+ verified molecular binding predictions, blockchain-anchored provenance, and spectral verification methods that have identified promising compounds across therapeutic areas. 🧠 Daugherty Engine — Novel neural architectures built on the principle that geometry is all you need, replacing attention mechanisms with topological constraints. 🔐 Post-Quantum Security Research — Identifying vulnerabilities in next-generation cryptographic standards before they become critical infrastructure. Why #NVIDIA Inception matters: Access to world-class technical #expertise, advanced hardware #resources, and a network of #innovators pushing the boundaries of what’s possible. We’re not just using GPUs — we’re rethinking how intelligence should be computed. To the team at @NVIDIA: thank you for believing in unconventional approaches. To our partners and collaborators: the best is ahead. The future belongs to those who build it. @Sdot2121 @Codenlighten1 @jalexanderm
20
35
6
127
8,757
Axiom has 15M compounds with 3.1M scaffolds → almost every 5th compound is a new chemical family That's 20% novelty rate vs industry standard of <1%.
One week ago, @OriginNeuralAI released #Axiom. a proof-of-concept with 5,600 predictions. Today, we crossed 15 million. Not 15 million random SMILES strings. 15 million binding-scored, scaffold-enriched, #blockchain-anchored #molecular #predictions -- each one evaluated by a 73,352-parameter sovereign proof engine, tagged with a patent freedom-to-operate signal, and catalogued into a live #marketplace anyone can browse right now. We didn't just scale a model. We built a molecular discovery #factory -- and opened the doors. Read on 👇 originneuralai.hashnode.dev/…
1
3
11
492
Introducing AxiomVault: The World's First Blockchain-Native Molecular IP Marketplace Today, we're launching AxiomVault — a platform that fundamentally changes how #drugdiscovery #IP is created, verified, and transacted. The Problem Drug discovery is a $200B industry plagued by: - Priority disputes — Who discovered it first? - IP uncertainty — Is this scaffold already patented? - Inefficient licensing — Months of negotiation for a single compound Our Solution AxiomVault combines three breakthrough technologies: 🧬 The Axiom Engine Our AI predicts drug-like molecules with binding affinities, ADMET profiles, and synthesis routes. We're generating novel scaffolds faster than traditional discovery can validate them. ⛓️ The Provenance Chain Every discovery is anchored to Bitcoin SV the instant it's created. This isn't just a timestamp — it's an immutable record that holds up in patent disputes, M&A due diligence, and regulatory filings. 📜 Smart Licensing Four tiers. One click. From evaluation to full IP ownership, every transaction is recorded on-chain and legally binding. For Pharma & Biotech Stop reinventing the wheel. Search our library of #AI-predicted compounds. Find scaffolds in your therapeutic area. License what you need. Skip years of early-stage discovery. - Preview leads before committing - Lock exclusive rights in your field - Acquire full IP with chain-of-title documentation For Investors & Acquirers Due diligence, solved. Every compound on AxiomVault comes with: - Verified discovery date - Complete licensing history - On-chain ownership record No more "trust us" — verify it yourself at axiomvault.io/verify The future of molecular IP is transparent, verifiable, and on-chain. Welcome to AxiomVault. axiomvault.io/
1
9
19
572
Earlier today I published "100,000 Molecules." The Axiom discovery engine by @OriginNeuralAI is now running at 202 molecules/minute — nearly 2x the rate when I hit publish this afternoon. But here's what matters more than volume: The AI is getting MORE creative, not less. At 100K, the last 2,000 compounds showed 83.2% unique scaffolds. At 107K, it's 83.7% — still climbing. Compare first 5,000 vs last 5,000: → Early cohort: 60.6% diversity → Late cohort: 76.6% diversity → 3,273 scaffolds in the late set that don't exist in the early set This is the opposite of what generative AI usually does. Most models front-load novelty and then collapse into variations. Axiom inverts that curve. • 107,000+ total predictions • 9,068 unique Murcko scaffolds (+523 in 5 hours) • 202/min sustained throughput • Zero signs of creative exhaustion At this pace, we hit 200K in under 8 hours. One @nvidia 8-core server. Seven Docker containers. A 73K-parameter model. The weight manifold doesn't lie.
1
5
12
343
Replying to @ruthheasman
Great question. You’re watching our AI explore possible new medicines. Each ‘molecule’ the worm absorbs is a computer-designed chemical structure that could potentially become a drug. As it moves, the system is testing whether that molecule is likely to bind to a biological target, whether it follows basic drug-likeness rules, and whether it looks truly novel. So it’s essentially a live visualization of AI searching through chemical space for promising treatments.
1
2
5
106
In the last 60 seconds: • +31 molecular predictions • +30 verified against geometric constraints • +29 drug-like compounds added to the marketplace • 0 human intervention The system didn't wait for a prompt. It mutated verified hits, generated new candidates, predicted their binding affinity, verified the results, and queued the next generation. While I typed this post, it did it again. The receipts are on-chain. This is #Axiom by @OriginNeuralAI — #autonomous molecular discovery grounded in #physics, not chat completions. The machines are working. The queue never empties. #AI #DrugDiscovery #AutonomousSystems
2
11
2
18
601
This is the coolest thing ever. github.com/OriginNeuralAI/Ax…
3
11
323
OriginNeuralAI retweeted
Elon Musk
@elonmuskFeb 8
Clawdbot 😂
mitsuri
@0xmitsuriiFeb 7
How was the show Silicon Valley so ahead of its time?
3,182
5,627
406
79,549
18,156,558
Just ran a fresh docking on BRAF V600E (#melanoma) using BioPrime on the #Daugherty Engine. Top hit came back as ibuprofen at –5.80 kcal/mol. This is #decentralized, #AI-powered drug discovery in real time—take it for a spin: huggingface.co/spaces/GotTha…
2
5
2
16
1,566
OriginNeuralAI retweeted
"Finding cures shouldn't be locked behind pharma boardrooms." @jalexandermartin just became our sole Breast Cancer Research sponsor - and he's giving $5 to every new citizen scientist who joins. 1 million compounds. Free. 🎀 bioprime.one
3
2
5
652
OriginNeuralAI retweeted
We are proud to announce TopoGrammar, a platform designed to illuminate the "dark matter" of the genome. While traditional pipelines focus on dosage, #TopoGrammar focuses on topology.
Introducing TopoGrammar: Cracking the "VUS" Code with 3D Genomics & Blockchain 68% of identified ##genomic variants are currently classified as "Variants of Uncertain Significance" (#VUS). For patients, this means a #diagnostic dead end. The Problem: Conventional sequencing misses "balanced" structural variants, inversions and translocations that don't change gene dosage but do wreck the genome's 3D regulatory architecture. The Solution: #TopoGrammar treats chromatin organization as a structured language. By modeling enhancers and promoters as "grammatical sentences," we identify disruptions that others miss. The Tech:🧬 PINNs: Physics-informed neural networks for high-fidelity 3D reconstruction. 🎯 - CTCF-Gating: 91% boundary detection accuracy (outperforming HiCCUPS). ⛓️ #Blockchain - Attestation: Every result is hashed to the #BSV blockchain for immutable, @US_FDA-compliant verification without exposing PHI. The Results:• 68% VUS reclassification rate. • 93% pathogenic accuracy. • Seamless integration with @BioPrimeAI v4.0 for genome-to-drug workflows. Stop guessing on VUS. Start decoding the #3Dgenome. 🔗 Try the Live Demo: huggingface.co/spaces/GotTha… @SmartLedgerTech @bioprimeai @Sdot2121 @Codenlighten1 @jalexanderm @grok #Genomics #PrecisionMedicine #AI #Biotech
1
1
2
73
Proud that @SmartLedgerTech maintains #USFCR federal contractor status and active government POCs. Building #blockchain solutions that meets DOD and federal #compliance standards. This is how you prove blockchain works beyond speculation. 🇺🇸⛓️ w/ @jalexanderm @Codenlighten1 @Sdot2121
1
7
4
33
785
We didn’t discover them. We kept running into them. The rest of the story will settle at the proper time. @SmartLedgerTech @Codenlighten1 @Sdot2121 @jalexanderm
2
4
32
849
Some numbers aren’t learned. They’re encountered. @SmartLedgerTech @Codenlighten1 @Sdot2121 @jalexanderm
5
16
430
We thought it was noise. Noise doesn’t line up this clean @SmartLedgerTech @Codenlighten1 @sdot21 @jalexanderm
1
5
25
626